Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
3.10    -0.15 (-4.76%)
Bid:
3.00
Ask:
3.20
Spread: 0.20 (6.667%)
Market Cap: £4.49m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Director/PDMR Shareholding

20 Dec 2024 07:00

RNS Number : 8470Q
Ondo InsurTech PLC
20 December 2024
 

20 December 2024

 

Ondo InsurTech plc

("Ondo" or the "Company")

 

Grant of Options

 

Ondo InsurTech plc (LSE: ONDO), a leading company in claims prevention technology for home insurers, the Company's Remuneration Committee has approved the grant options over 2,045,372 ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the Company's Enterprise Management Incentive Plan (the "EMI Options") and options over a further 1,854,628 Ordinary Shares as Unapproved Share Options ("Unapproved Options").

 

The EMI Options and the Unapproved Options (together the "Options") are exercisable at a price of 36.5p, being the average closing share price over the 10 business days to 19 December 2024 and will vest across the 48 months from the date of grant. Once vested the Options may be exercised at any time before the fifth anniversary of the date of the award.

 

The Options comprise:

 

1. The award of 855,372 EMI Options and 1,604,628 Unapproved Options to the following directors of the Company:

 

Name

Position

Number of Ordinary Shares over which Options granted

Total number of Ordinary Shares over which Options held following grant

Total number of Ordinary Shares held

Percentage of Current Issued Share Capital held

Craig Foster

Chief Executive Officer

1,600,000

3,919,999

1,990,986

1.7%

Kevin Withington

Chief Financial Officer

600,000

1,289,071

294,480

0.3%

Mark Wood

Chairman

260,000

260,000

2,155,152

1.9%

 

 

2. EMI Options over 1,190,000 Ordinary Shares granted to other employees of the Company on the same terms as those awarded to the Directors.

 

3. Unapproved Options of 250,000 Ordinary Shares granted to certain other employees that do not qualify under the EMI plan, also on the same terms as the Directors.

 

Following the grant of Options, the total number of Options outstanding over unissued Ordinary Shares is 10,441,618 representing approximately 8.62% of the Company's issued share capital.

 

Enquiries

 

For further information, please visit www.ondoplc.com or contact the following:  

 

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

 

+44 (0) 800 783 9866

Dowgate Capital Limited

(Broker & Financial Advisor)

Russell Cook

Nicholas Chambers

Charlie Hall

 

+44 (0) 20 3903 7715

 

Cassiopeia Services Limited

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

  

 

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a) 

Name 

 

Craig Foster

2

 

Reason for the notification

 

a)

 

Position/status 

 

Chief Executive Officer and PDMR

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Ondo InsurTech Plc

b)

 

LEI

2138005Y5QBJQMOOI719

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

ISIN: GB00BNVVGD77 

b)

 

Nature of the transaction

 

 

Grant of options under EMI plan share and further non-approved share options

c)

 

Price(s) and volume(s)

Exercise price: 36.5p

 

EMI Options

Unapproved Options

136,986

1,463,014

 

 

d)

 

Aggregated information

 

 

n/a

 

e)

 

Date of the transaction

 

20 December 2024

f)

 

Place of the transaction

 

Outside of a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a) 

Name 

 

Kevin Withington

2

 

Reason for the notification

 

a)

 

Position/status 

 

Chief Financial Officer and PDMR

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Ondo InsurTech Plc

b)

 

LEI

2138005Y5QBJQMOOI719

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

ISIN: GB00BNVVGD77 

b)

 

Nature of the transaction

 

 

Grant of options under EMI plan share and further non-approved share options

c)

 

Price(s) and volume(s)

Exercise price: 36.5p

 

EMI Options

Unapproved Options

458,386

141,614

 

 

d)

 

Aggregated information

 

 

n/a

 

e)

 

Date of the transaction

 

20 December 2024

f)

 

Place of the transaction

 

Outside of a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a) 

Name 

 

Mark Wood

2

 

Reason for the notification

 

a)

 

Position/status 

 

Chairman and PDMR

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Ondo InsurTech Plc

b)

 

LEI

2138005Y5QBJQMOOI719

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

ISIN: GB00BNVVGD77 

b)

 

Nature of the transaction

 

 

Grant of options under EMI plan share

c)

 

Price(s) and volume(s)

Exercise price: 36.5p

 

260,000

 

 

d)

 

Aggregated information

 

 

n/a

 

e)

 

Date of the transaction

 

20 December 2024

f)

 

Place of the transaction

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFFVFILALIS
Date   Source Headline
2nd Jun 20265:56 pmRNSShare Incentive Plan Purchase
28th May 20267:00 amRNSVendor Loan Note Restructuring
21st May 20267:00 amRNSAppointment of Non-Executive Director
6th May 20267:00 amRNSShare Incentive Plan Purchase
23rd Apr 202611:01 amRNSChange of Board Responsibilities
21st Apr 20263:30 pmRNSTrading Update for the Year Ended 31 March 2026
13th Apr 20267:00 amRNS-RAlm. Brand Group Extends LeakBot Programme
13th Apr 20267:00 amRNSBoard Changes
8th Apr 202610:59 amRNSShare Incentive Plan Purchase
4th Mar 20265:19 pmRNSShare Incentive Plan Purchase
4th Mar 20267:00 amRNSOndo Extends Contract with Selective Insurance
12th Feb 20267:00 amRNSU.S. Contract Win
9th Feb 20267:00 amRNSAlm. Brand Group to roll out LeakBot
30th Jan 20264:50 pmRNSBlock Listing Update - Warrant Plan
30th Jan 20262:01 pmRNSBlock Listing Update - Option Plan
30th Jan 20262:00 pmRNSDirector/PDMR Shareholding
14th Jan 20267:00 amRNSAppointment of Joint Corporate Broker
2nd Jan 20264:45 pmRNSDirector/PDMR Shareholding
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
17th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20259:50 amRNSHolding(s) in Company
9th Dec 20257:00 amRNSIssue of Equity - Result of WRAP Retail Offer
5th Dec 20253:21 pmRNSUpdate to Placing and Admission
4th Dec 20257:50 amRNSLaunch of WRAP Retail Offer
4th Dec 20257:00 amRNSResult of ABB
3rd Dec 20257:00 amRNSPlacing and Subscription via ABB
3rd Dec 20257:00 amRNSHalf-year Financial Report
1st Dec 20257:00 amRNSChange of Registered Office
27th Nov 20253:33 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSNotice of Results
24th Nov 20257:00 amRNSContract
19th Nov 20257:00 amRNSContract Win
10th Nov 20257:00 amRNSContract Win
3rd Nov 20255:01 pmRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTotal Voting Rights
9th Oct 202510:46 amRNSDirector/PDMR Shareholding
30th Sep 20254:58 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSTotal Voting Rights
22nd Sep 20254:08 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
4th Sep 20253:30 pmRNSDirector/PDMR Shareholding
3rd Sep 20257:00 amRNSContract
26th Aug 20257:00 amRNS-RTopdanmark agreement update
15th Aug 20253:00 pmRNSNotice of AGM
4th Aug 20254:47 pmRNSHolding(s) in Company
4th Aug 20253:10 pmRNSHolding(s) in Company
4th Aug 20257:00 amRNSDirectorate Change
1st Aug 20251:32 pmRNSDirector/PDMR Shareholding
1st Aug 20259:03 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.